Average Co-Inventor Count = 6.91
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biomarin Pharmaceutical Inc. (12 from 136 patents)
12 patents:
1. 11254725 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
2. RE48267 - Variants of C-type natriuretic peptide
3. 10301369 - Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins
4. RE46707 - Variants of C-type natriuretic peptide
5. 9845346 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
6. 9834587 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
7. 9834588 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
8. 9771408 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
9. 9376480 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
10. 8598121 - Variants of C-type natriuretic peptide
11. 8377884 - Variants of C-type natriuretic peptides
12. 8198242 - Variants of C-type natriuretic peptide